|
1）Breakefield XO, Blood AJ, Li Y, et al. The pathophysiological basis of dystonias. Nat Rev Neurosci. 2008; 9: 222-34
|
|
|
|
2）後藤 惠. ジストニアの病理・機能解剖．梶 龍兒，編．ジストニアのすべて．東京: 診断と治療社; 2013. p.39-47
|
|
|
|
|
|
3）Neychev VK, Gross RE, Lehericy S, et al. The functional neuroanatomy of dystonia. Neurobiol Dis. 2011; 42: 185-201
|
|
|
|
|
4）Müller U. The monogenic primary dystonias. Brain. 2009; 132: 2005-25
|
|
|
|
|
|
5）Lee LV, Pascasio FM, Fuentes FD, et al. Torsion dystonia in Panay, Philippines. Adv Neurol. 1976; 14: 137-51
|
|
|
|
|
|
6）Lee LV, Maranon E, Demaisip C, et al. The natural history of sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Parkinsonism Relat Disord. 2002; 9: 29-38
|
|
|
|
|
|
7）Evidente VGH, Lyons MK, Wheeler M, et al. First case of X-linked dystonia-parkinsonism (“Lubag”) to demonstrate a response to bilateral pallidal stimulation. Mov Disord. 2007; 22: 1790-3
|
|
|
|
|
|
8）Deng H, Le W-D, Jankovic J. Genetic study of an American family with DYT3 dystonia (Lubag). Neurosci Lett. 2008; 448: 180-3
|
|
|
|
|
|
9）Martinez-Torres I, Limousin P, Tisch S, et al. Early and marked benefit with GPi DBS for Lubag syndrome presenting with rapidly progressive life-threatening dystonia. Mov Disord. 2009; 24: 1710-2
|
|
|
|
|
|
10）Nolte D, Niemann S, Muller U. Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism. Proc Natl Acad Sci U S A. 2003; 100: 10347-52
|
|
|
|
|
|
11）Muller U, Herzfeld T, Nolte D. The TAF1/DYT3 multiple transcript system in X-linked dystonia-parkinsonism. Am J Hum Genet. 2007; 81: 415-7
|
|
|
|
|
|
12）Makino S, Kaji R, Ando S, et al. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet. 2007; 80: 393-406
|
|
|
|
|
|
13）Kawarai T, Pasco PMD, Teleg RA, et al. Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia-parkinsonism. Neurogenetics. 2013; 14: 167-9
|
|
|
|
|
|
14）Waters CH, Faust PL, Powers J, et al. Neuropathology of Lubag (X-linked dystonia parkinsonism). Mov Disord. 1993; 8: 387-90
|
|
|
|
|
|
15）Goto S, Lee LV, Munoz EL, et al. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol. 2005; 58: 7-17
|
|
|
|
|
|
16）Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990; 13: 244-54
|
|
|
|
|
|
17）Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 1992; 15: 133-9
|
|
|
|
|
|
18）Graybiel AM. Habits, rituals, and the evaluative brain. Annu Rev Neurosci. 2008; 31: 359-87
|
|
|
|
|
|
19）Crittenden JR, Graybiel AM. Basal ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front Neuroanat. 2011; 5: 1-25
|
|
|
|
|
|
20）Goto S, Kawarai T, Morigaki R, et al. Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism. Brain. 2013; 136: 1555-67
|
|
|
|
|
|
21）Evidente VG, Advincula J, Esteban R, et al. Phenomenology of “Lubag” or X-linked dystonia-parkinsonism. Mov Disord. 2002; 17: 1271-7
|
|
|
|
|
|
22）Evidente VGH. X-linked dystonia-parkinsonism. In: Pagon RA, Adam MF, Ardinger HH, et al. editors. GeneReviews [Internet]. Seattle: University of Washington; 1993-2014. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1489/
|
|
|
|
|
|
23）Howe LL, Kellison IL, Fernandez HH, et al. Neuropsychological profile of Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease. Clin Neuropsychol. 2009; 23: 100-17
|
|
|
|
|
|
24）Gillian LS. Pathological gambling in X-linked dystonia parkinsonism. J Addict Med. 2013; 7: 299-301
|
|
|
|
|
|
25）Piano AN, Tan LC. Impulse control disorder in a patient with X-linked dystonia-parkinsonism after bilateral pallidal deep brain stimulation. Parkinsonism Relat Disord. 2013; 19: 1069-70
|
|
|
|
|
|
26）Morigaki R, Nakataki M, Kawarai Y, et al. Depression in X-linked dystonia-parkinsonism: a case-control study. Parkinsonism Relat Disord. 2013; 19: 844-6
|
|
|
|
|
|
27）Eidelberg D, Takikawa S, Wilhelmsen K, et al. Positron emission tomographic findings in Filipino X-linked dystonia-parkinsonism. Ann Neurol. 1993; 34: 185-91
|
|
|
|
|
|
28）Rosales RL. X-linked dystonia Parkinsonism: clinical phenotype, genetics and therapeutics. J Mov Disord. 2010; 3: 32-8
|
|
|
|
|
|
29）Rosales RL, Santos MM, Ng AR, et al. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystonias. Int J Neurosci. 2011; 121 Suppl 1: 35-43
|
|
|
|
|
|
30）Rosales RL, Ng AR, Santos MM. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias. Int J Neurosci. 2011; 121 Suppl 1: 44-56
|
|
|
|
|
|
31）Wadia PM, Lim S-Y, Lozano AM, et al. Bilateral pallidal stimulation for X-linked dystonia parkinsonism. Arch Neurol. 2010; 67: 1012-5
|
|
|
|
|
|
32）Aguilar JA, Vesagas TS, Jamora RD, et al. The promise of deep brain stimulation in X-linked dystonia parkinsonism. Int J Neurosci. 2011; 121 Suppl 1: 57-63
|
|
|
|
|
|
33）Oyama G, Fernandez HH, Foote KD, et al. Differential response of dystonia and parkinsonism following globus pallidus internus deep brain stimulation in X-linked dystonia-parkinsonism (Lubag). Stereotact Funct Neurosurg. 2012; 88: 329-33
|
|
|
|
|
|
34）Patel AJ, Sarwar AI, Jankovic J, et al. Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism. World Neurosurg. 2014; 82: 241
|
|
|
|
|
|
35）Herzfeld T, Nolte D, Grnarova M, et al. X-linked dystonia parkinsonism (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism. Hum Mol Genet. 2013; 22: 941-51
|
|
|
|
|
|
36）Pisani A, Bernardi G, Ding, et al. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci. 2007; 30: 545-53
|
|
|
|
|
|
37）Decressac M, Barker RA. Neuropeptide Y and its role in CNS disease and repair. Exp Neurol. 2012; 238: 265-72
|
|
|
|
|
|
38）Fuchs T, Saunders-Pullman R, Masuho I, et al. Mutations in GNAL cause primary torsion dystonia. Nat Genet. 2013; 45: 88-92
|
|
|
|
|
|
39）Kumar KR, Lohmann K, Masuho I, et al. Mutations in GNAL: a novel cause of craniocervical dystonia. JAMA Neurol. 2014; 71: 490-4
|
|
|
|
|
|
40）Petrucci S, Valente EM. Genetic issues in the diagnosis of dystonias. Front Neurol. 2013; 4: 34
|
|
|
|
|